Wednesday, July 28, 2021
Gene Point Mutation/Knock-in Cell Lineas low as $8480 | Ubigene
Ubigene Biosciences, is a fast-growing company with an experienced team in gene-editing. Our advanced molecular and cell biology platform ensure us to provide high-quality services and products for biological research and biotechnology industries.
Subscribe to:
Post Comments (Atom)
[Research highlight] Enhancing p53 pathway can efficiently suppress colon cancer
Colorectal cancer is the third most diagnosed cancer and leads to the second mortality among cancers worldwide. The first-line chemotherap...
-
Background In 1996, U-87 MG cell line was isolat ed from the malignant glioma of a 44-year-old female patient. This human primary gliob...
-
Colorectal cancer is the third most diagnosed cancer and leads to the second mortality among cancers worldwide. The first-line chemotherap...
No comments:
Post a Comment